Sativex: Clinical Efficacy And Tolerability In The Treatment Of Symptoms Of Multiple Sclerosis And Neuropathic Pain

Multiple Sclerosis (MS)

Key Findings

Reduction in spasticity, neuropathic pain, and neuropathic pain of other etiologies.

Information and Links


Link: Sativex: Clinical Efficacy And Tolerability In The Treatment Of Symptoms Of Multiple Sclerosis And Neuropathic Pain

Year: 2006

DOI: 10.1517/14656566.7.5.607


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Sativex as an oromucosal spray; each spray delivers 2.7 mg THC and 2.5 mg CBD. Average use in this study was 22–32 mg/day THC and 20–30 mg/day CBD.